relax- AOD and the personal care rollout will fund the company overheads going forward IMHO. AOD alone is a company maker and should generate substantial cash this year for POH.
Of course POH will need to raise the funds to complete its final TPM Oxy trials - but they will wait to do it and at much higher levels than todays sp.
Meanwhile we have seen the last raising to run POHs day to day ops. With this behind us,Numerous Drug and Cosmecuetical deals in the works and a derisked tech platform -Its Blue Sky ahead.
KC
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.28M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $24.10K | 5.355M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 10266426 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 17562909 | 21 |
View Market Depth
| Last trade - 15.05pm 11/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |